FMS

Fresenius Medical Care AG & Co. KGaA [FMS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

FMS Stock Summary

Top 10 Correlated Stocks

FMS


In the News

12:11 29 Mar 2024 FMS

Fresenius Medical (FMS) to Unveil Training on Augmented Reality

Fresenius Medical (FMS) is launching digital learning elements with hands-on training for Kidney Replacement Therapy leveraging Augmented Reality.

08:56 29 Mar 2024 FMS

Fresenius Medical (FMS) Q4 Earnings Beat, Operating Margin Up

Fresenius Medical's (FMS) fourth-quarter revenues suffer due to unfavorable currency movement. However, the company?

12:03 29 Mar 2024 FMS

Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript

Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript

11:51 29 Mar 2024 FMS

Fresenius Medical (FMS) Gets FDA Nod for New Hemodialysis System

Fresenius Medical (FMS) receives an FDA nod for its new 5008X Hemodialysis System that aims to provide better dialysis therapy for kidney patients in the United States.

11:16 29 Mar 2024 FMS

Fresenius Medical (FMS) Divests Businesses to Optimize Portfolio

Fresenius Medical (FMS) streamlines for success with three key divestments in 2023. These divestments are likely to impact operating income by EUR 500 million in the fourth quarter.

02:16 29 Mar 2024 FMS

Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now

Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.

09:55 29 Mar 2024 FMS

Fresenius plans to sell rehabilitation care clinics - FAZ

Fresenius has hired UBS to manage the sale of its rehabilitation care clinic business as the German healthcare group focuses on core activities, Frankfurter Allgemeine Zeitung reported on Friday, citing financial sources.

09:52 29 Mar 2024 FMS

Fresenius Medical Care says data on 500,000 people stolen in U.S.

Dialysis group Fresenius Medical Care said on Wednesday that data including medical records on 500,000 patients and former patients were stolen from a U.S. subsidiary's database.

08:16 29 Mar 2024 FMS

Fresenius Medical (FMS) Ups '23 Outlook After Legal Settlement

Fresenius Medical (FMS) wins legal dispute against the U.S. government. Both revenues and operating income will benefit from the settlement agreement.

09:46 29 Mar 2024 FMS

Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now

Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.

FMS Financial details

Company Rating
Strong Buy
Market Cap
11B
Income
546.49M
Revenue
19.45B
Book val./share
46.42
Cash/share
5.25
Dividend
0.62
Dividend %
3.34%
Employees
119.85K
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
19.66
Forward P/E
10.15
PEG
22.61
P/S
0.56
P/B
0.78
P/C
3.67
P/FCF
6.61
Quick Ratio
0.8
Current Ratio
1.37
Debt / Equity
0.88
LT Debt / Equity
0.71
-
-
EPS (TTM)
1.25
EPS next Y
1.9
EPS next Q
0.28
EPS this Y
47.83%
EPS next Y
52.19%
EPS next 5Y
140.68%
EPS last 5Y
-3%
Revenue last 5Y
2.17%
Revenue Q/Q
1.05%
EPS Q/Q
357.14%
-
-
-
-
SMA20
-1.99%
SMA50
-4.25%
SMA100
13.77%
Inst Own
5.56%
Inst Trans
0.96%
ROA
2%
ROE
4%
ROC
0.03%
Gross Margin
25%
Oper. Margin
4%
Profit Margin
3%
Payout
-
Shs Outstand
586.83M
Shs Float
586.39M
-
-
-
-
Target Price
19.35
52W Range
16.37-27.72
52W High
-28.59%
52W Low
+20.5%
RSI
47.2
Rel Volume
0.45
Avg Volume
451.53K
Volume
204.41K
Perf Week
-1.28%
Perf Month
-9.06%
Perf Quarter
-7.53%
Perf Half Y
-11.68%
-
-
-
-
Beta
0.935
-
-
Volatility
0.29%, 0.66%
Prev Close
-0.41%
Price
19.28
Change
1.53%

FMS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
28.8730.3730.0733.0733.15
Net income per share
1.981.981.651.150.85
Operating cash flow per share
4.247.24.253.694.48
Free cash flow per share
0.543.651.381.293.31
Cash per share
1.882.112.762.462.62
Book value per share
21.8520.9723.8626.3423.21
Tangible book value per share
-3.66-3.42-3.14-3.17-2.02
Share holders equity per share
21.8520.9723.8626.3423.21
Interest debt per share
23.5821.7523.3423.1421.11
Market cap
19.81B19.99B16.79B8.98B11.28B
Enterprise value
32.58B31.29B28.63B20.92B21.93B
P/E ratio
16.5117.1717.3213.3422.61
Price to sales ratio
1.131.120.950.460.58
POCF ratio
7.724.726.754.154.29
PFCF ratio
60.219.3220.8311.885.8
P/B Ratio
1.51.621.20.580.83
PTB ratio
1.51.621.20.580.83
EV to sales
1.861.751.631.081.13
Enterprise value over EBITDA
14.1513.5214.8713.246.38
EV to operating cash flow
12.697.3911.59.658.34
EV to free cash flow
99.0414.5935.5227.6711.28
Earnings yield
0.060.060.060.070.04
Free cash flow yield
0.020.110.050.080.17
Debt to equity
1.0410.950.860.88
Debt to assets
0.420.390.390.370.36
Net debt to EBITDA
5.554.886.157.563.1
Current ratio
1.021.181.11.271.42
Interest coverage
1.451.290.85-0.724.46
Income quality
1.782.952.042.425.27
Dividend Yield
0.020.020.020.040.03
Payout ratio
0.30.30.40.590.66
Sales general and administrative to revenue
00000
Research and developement to revenue
0.010.010.010.010.01
Intangibles to total assets
0.470.450.460.480.47
Capex to operating cash flow
-0.87-0.49-0.68-0.65-0.26
Capex to revenue
-0.13-0.12-0.1-0.07-0.04
Capex to depreciation
-1.4-1.17-1.04-0.77-0.39
Stock based compensation to revenue
0-0.11-0.100.02
Graham number
31.2230.5629.826.0921.07
ROIC
0.020.020.01-0.010.03
Return on tangible assets
0.070.070.050.040.03
Graham Net
-24.38-24.58-25.3-25.05-22.88
Working capital
157.77M1.12B709M1.74B2.59B
Tangible asset value
-2.22B-2.01B-1.84B-1.86B-1.19B
Net current asset value
-12.54B-12.08B-12.42B-12.1B-10.4B
Invested capital
1.0410.950.860.88
Average receivables
3.87B3.79B3.76B3.97B4.05B
Average payables
815.12M831.29M842.46M894.43M908.24M
Average inventory
1.57B1.78B1.97B2.17B2.24B
Days sales outstanding
82.973.9780.9375.8676.19
Days payables outstanding
25.2324.5124.9624.1322.24
Days of inventory on hand
50.2556.1459.3159.4954.75
Receivables turnover
4.44.934.514.814.79
Payables turnover
14.4614.8914.6315.1316.41
Inventory turnover
7.266.56.156.146.67
ROE
0.090.090.070.040.04
Capex per share
-3.7-3.55-2.87-2.41-1.17

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
8.528.028.228.4117
Net income per share
0.330.230.240.140.64
Operating cash flow per share
1.020.241.721.292.45
Free cash flow per share
0.2901.451.061.6
Cash per share
2.462.092.322.655.25
Book value per share
26.3323.5623.0523.8746.42
Tangible book value per share
-3.17-2.84-3.23-2.35-4.04
Share holders equity per share
26.3323.5623.0523.8746.42
Interest debt per share
22.6922.7722.4422.341.36
Market cap
8.99B11.44B12.92B12.06B5.64B
Enterprise value
20.93B23.48B24.63B23.48B16.29B
P/E ratio
11.5821.3723.0135.747.5
Price to sales ratio
1.82.432.682.441.13
POCF ratio
14.9880.112.8315.877.84
PFCF ratio
53.1816.25K15.1719.3612.03
P/B Ratio
0.580.830.960.860.41
PTB ratio
0.580.830.960.860.41
EV to sales
4.194.995.14.763.27
Enterprise value over EBITDA
55.5132.6128.5129.2318.5
EV to operating cash flow
34.88164.4124.4530.9122.65
EV to free cash flow
123.8233.36K28.9137.6934.74
Earnings yield
0.020.010.010.010.03
Free cash flow yield
0.0200.070.050.08
Debt to equity
0.860.960.970.930.88
Debt to assets
0.370.370.370.360.36
Net debt to EBITDA
31.6716.7213.5514.2212.09
Current ratio
1.271.321.261.371.42
Interest coverage
-1.182.763.412.855.16
Income quality
3.091.075.175.173.82
Dividend Yield
000.0300
Payout ratio
002.3400
Sales general and administrative to revenue
00000
Research and developement to revenue
0.010.010.010.010.01
Intangibles to total assets
0.480.480.480.470.47
Capex to operating cash flow
-0.72-1-0.15-0.18-0.35
Capex to revenue
-0.09-0.03-0.03-0.03-0.05
Capex to depreciation
-0.87-0.32-0.36-0.3-0.59
Stock based compensation to revenue
00-0.02-0.050.04
Graham number
13.991111.148.7925.86
ROIC
00.010.010.010.01
Return on tangible assets
0.010.010.0100.01
Graham Net
-25.03-25.37-25.16-25.07-45.77
Working capital
1.74B2.07B1.72B2.43B2.59B
Tangible asset value
-1.86B-1.67B-1.89B-1.38B-1.19B
Net current asset value
-12.1B-11.71B-11.68B-11.15B-10.4B
Invested capital
0.860.960.970.930.88
Average receivables
4B4.01B3.82B3.68B3.89B
Average payables
920.13M922.45M866.39M831.99M864.96M
Average inventory
2.35B2.31B2.33B2.32B2.24B
Days sales outstanding
72.6176.4468.0167.7273.27
Days payables outstanding
22.9723.1320.3220.5121.9
Days of inventory on hand
56.6358.9457.9355.9353.91
Receivables turnover
1.241.181.321.331.23
Payables turnover
3.923.894.434.394.11
Inventory turnover
1.591.531.551.611.67
ROE
0.010.010.010.010.01
Capex per share
-0.73-0.24-0.26-0.23-0.85

FMS Frequently Asked Questions

What is Fresenius Medical Care AG & Co. KGaA stock symbol ?

Fresenius Medical Care AG & Co. KGaA is a DE stock and trading under the symbol FMS

Is Fresenius Medical Care AG & Co. KGaA buy or a sell ?

2 stock analysts have 2 predictions with a medium analyst target price of $19.35. The lowest prediction is $11.7 and the highest is $27

What is FMS stock prediction ?

What is Fresenius Medical Care AG & Co. KGaA stock quote today ?

Fresenius Medical Care AG & Co. KGaA stock price is $19.28 today.

Is Fresenius Medical Care AG & Co. KGaA stock public?

Yes, Fresenius Medical Care AG & Co. KGaA is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks